Drug Shortage Report for ERYTHROMYCIN OPHTHALMIC OINTMENT USP

Last updated on 2021-12-16 History
Report ID 9975
Drug Identification Number 02326663
Brand name ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP
Common or Proper name Erythromycin Ophthalmic Ointment USP
Company Name STERI-MED PHARMA INC.
Market Status MARKETED
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 5MG
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 1 g
ATC code S01AA
ATC description ANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-09
Estimated end date 2021-12-15
Actual end date 2021-12-15
Shortage status Resolved
Updated date 2021-12-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 242, RUE SAINT-CYRILLE OUEST
UPTON, QUEBEC
CANADA J0H 2E0
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-05-10 English Compare
v2 2017-05-10 French Compare
v3 2017-07-04 English Compare
v4 2017-07-04 French Compare
v5 2017-10-17 English Compare
v6 2017-10-17 French Compare
v7 2017-11-15 English Compare
v8 2017-11-15 French Compare
v9 2018-02-01 English Compare
v10 2018-02-01 French Compare
v11 2018-04-03 English Compare
v12 2018-04-03 French Compare
v13 2018-05-31 English Compare
v14 2018-05-31 French Compare
v15 2018-09-07 English Compare
v16 2018-09-07 French Compare
v17 2019-04-30 English Compare
v18 2019-04-30 French Compare
v19 2019-09-18 English Compare
v20 2019-09-18 French Compare

Showing 1 to 20 of 33